252 related articles for article (PubMed ID: 24286213)
21. Adiponectin and cardiovascular health: an update.
Hui X; Lam KS; Vanhoutte PM; Xu A
Br J Pharmacol; 2012 Feb; 165(3):574-90. PubMed ID: 21457225
[TBL] [Abstract][Full Text] [Related]
22. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.
Gallo S; Sala V; Gatti S; Crepaldi T
Clin Sci (Lond); 2015 Dec; 129(12):1173-93. PubMed ID: 26561593
[TBL] [Abstract][Full Text] [Related]
23. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
Horváth B; Magid L; Mukhopadhyay P; Bátkai S; Rajesh M; Park O; Tanchian G; Gao RY; Goodfellow CE; Glass M; Mechoulam R; Pacher P
Br J Pharmacol; 2012 Apr; 165(8):2462-78. PubMed ID: 21449982
[TBL] [Abstract][Full Text] [Related]
24. Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.
Kawai H; Sato W; Yuzawa Y; Kosugi T; Matsuo S; Takei Y; Kadomatsu K; Muramatsu T
Am J Pathol; 2004 Nov; 165(5):1603-12. PubMed ID: 15509530
[TBL] [Abstract][Full Text] [Related]
25. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.
Takenaka H; Horiba M; Ishiguro H; Sumida A; Hojo M; Usui A; Akita T; Sakuma S; Ueda Y; Kodama I; Kadomatsu K
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H462-9. PubMed ID: 19060126
[TBL] [Abstract][Full Text] [Related]
26. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
27. Midkine Promotes Atherosclerotic Plaque Formation Through Its Pro-Inflammatory, Angiogenic and Anti-Apoptotic Functions in Apolipoprotein E-Knockout Mice.
Takemoto Y; Horiba M; Harada M; Sakamoto K; Takeshita K; Murohara T; Kadomatsu K; Kamiya K
Circ J; 2017 Dec; 82(1):19-27. PubMed ID: 28781288
[TBL] [Abstract][Full Text] [Related]
28. Midkine's Role in Cardiac Pathology.
Woulfe KC; Sucharov CC
J Cardiovasc Dev Dis; 2017 Sep; 4(3):. PubMed ID: 28920060
[TBL] [Abstract][Full Text] [Related]
29. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors.
Zhang N; Deuel TF
Curr Opin Hematol; 1999 Jan; 6(1):44-50. PubMed ID: 9915553
[TBL] [Abstract][Full Text] [Related]
30. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis.
Weckbach LT; Groesser L; Borgolte J; Pagel JI; Pogoda F; Schymeinsky J; Müller-Höcker J; Shakibaei M; Muramatsu T; Deindl E; Walzog B
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H429-38. PubMed ID: 22707563
[TBL] [Abstract][Full Text] [Related]
31. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
Bátkai S; Mukhopadhyay P; Horváth B; Rajesh M; Gao RY; Mahadevan A; Amere M; Battista N; Lichtman AH; Gauson LA; Maccarrone M; Pertwee RG; Pacher P
Br J Pharmacol; 2012 Apr; 165(8):2450-61. PubMed ID: 21470208
[TBL] [Abstract][Full Text] [Related]
32. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
[TBL] [Abstract][Full Text] [Related]
33. The role of mitochondrial dynamics in cardiovascular diseases.
Forte M; Schirone L; Ameri P; Basso C; Catalucci D; Modica J; Chimenti C; Crotti L; Frati G; Rubattu S; Schiattarella GG; Torella D; Perrino C; Indolfi C; Sciarretta S;
Br J Pharmacol; 2021 May; 178(10):2060-2076. PubMed ID: 32294237
[TBL] [Abstract][Full Text] [Related]
34. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
[TBL] [Abstract][Full Text] [Related]
35. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
[TBL] [Abstract][Full Text] [Related]
36. Midkine Controls Arteriogenesis by Regulating the Bioavailability of Vascular Endothelial Growth Factor A and the Expression of Nitric Oxide Synthase 1 and 3.
Lautz T; Lasch M; Borgolte J; Troidl K; Pagel JI; Caballero-Martinez A; Kleinert EC; Walzog B; Deindl E
EBioMedicine; 2018 Jan; 27():237-246. PubMed ID: 29233575
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the inflammatory response of vascular endothelial cells by EPAC1.
Parnell E; Smith BO; Palmer TM; Terrin A; Zaccolo M; Yarwood SJ
Br J Pharmacol; 2012 May; 166(2):434-46. PubMed ID: 22145651
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts.
Fukui S; Kitagawa-Sakakida S; Kawamata S; Matsumiya G; Kawaguchi N; Matsuura N; Sawa Y
Ann Thorac Surg; 2008 Feb; 85(2):562-70. PubMed ID: 18222265
[TBL] [Abstract][Full Text] [Related]
39. Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways.
Pipicz M; Varga ZV; Kupai K; Gáspár R; Kocsis GF; Csonka C; Csont T
Br J Pharmacol; 2015 Jul; 172(14):3472-83. PubMed ID: 25827015
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
